Cargando…

Ebola Virus VP40 Modulates Cell Cycle and Biogenesis of Extracellular Vesicles

BACKGROUND: Ebola virus (EBOV) mainly targets myeloid cells; however, extensive death of T cells is often observed in lethal infections. We have previously shown that EBOV VP40 in exosomes causes recipient immune cell death. METHODS: Using VP40-producing clones, we analyzed donor cell cycle, extrace...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pleet, Michelle L, Erickson, James, DeMarino, Catherine, Barclay, Robert A, Cowen, Maria, Lepene, Benjamin, Liang, Janie, Kuhn, Jens H, Prugar, Laura, Stonier, Spencer W, Dye, John M, Zhou, Weidong, Liotta, Lance A, Aman, M Javad, Kashanchi, Fatah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Supplement Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249571/ https://www.ncbi.nlm.nih.gov/pubmed/30169850 http://dx.doi.org/10.1093/infdis/jiy472

Ejemplares similares

Extracellular Vesicles and Ebola Virus: A New Mechanism of Immune Evasion
por: Pleet, Michelle L., et al.
Publicado: (2019)

Ebola VP40 in Exosomes Can Cause Immune Cell Dysfunction
por: Pleet, Michelle L., et al.
Publicado: (2016)

Corrigendum: Ebola VP40 in Exosomes Can Cause Immune Cell Dysfunction
por: Pleet, Michelle L., et al.
Publicado: (2018)

HTLV-1 Extracellular Vesicles Promote Cell-to-Cell Contact
por: Pinto, Daniel O., et al.
Publicado: (2019)

An Omics Approach to Extracellular Vesicles from HIV-1 Infected Cells
por: Barclay, Robert A., et al.
Publicado: (2019)

Antiretroviral Drugs Alter the Content of Extracellular Vesicles from HIV-1-Infected Cells
por: DeMarino, Catherine, et al.
Publicado: (2018)

Publisher Correction: Antiretroviral Drugs Alter the Content of Extracellular Vesicles from HIV-1-Infected Cells
por: DeMarino, Catherine, et al.
Publicado: (2018)

Effect of transcription inhibition and generation of suppressive viral non-coding RNAs
por: Pinto, Daniel O., et al.
Publicado: (2019)

Extracellular Vesicle Activation of Latent HIV-1 Is Driven by EV-Associated c-Src and Cellular SRC-1 via the PI3K/AKT/mTOR Pathway
por: Barclay, Robert A., et al.
Publicado: (2020)

Identification of Modulators of HIV-1 Proviral Transcription from a Library of FDA-Approved Pharmaceuticals
por: Sampey, Gavin C., et al.
Publicado: (2020)

Presence of Viral microRNA in Extracellular Environments
por: DeMarino, Catherine, et al.
Publicado: (2017)

Differences in Transcriptional Dynamics Between T-cells and Macrophages as Determined by a Three-State Mathematical Model
por: DeMarino, Catherine, et al.
Publicado: (2020)

Low-Level Ionizing Radiation Induces Selective Killing of HIV-1-Infected Cells with Reversal of Cytokine Induction Using mTOR Inhibitors
por: Pinto, Daniel O., et al.
Publicado: (2020)

Extracellular vesicles from HTLV-1 infected cells modulate target cells and viral spread
por: Pinto, Daniel O., et al.
Publicado: (2021)

Cannabinoids Reduce Extracellular Vesicle Release from HIV-1 Infected Myeloid Cells and Inhibit Viral Transcription
por: DeMarino, Catherine, et al.
Publicado: (2022)

Zika Virus: A New Animal Model for an Arbovirus
por: Aman, M. Javad, et al.
Publicado: (2016)

Methamphetamine Induces the Release of Proadhesive Extracellular Vesicles and Promotes Syncytia Formation: A Potential Role in HIV-1 Neuropathogenesis
por: Chand, Subhash, et al.
Publicado: (2022)

Viral antigens detectable in CSF exosomes from patients with retrovirus associated neurologic disease: functional role of exosomes
por: Anderson, Monique R., et al.
Publicado: (2018)

Autophagy, EVs, and Infections: A Perfect Question for a Perfect Time
por: Pleet, Michelle L., et al.
Publicado: (2018)

Interplay between Autophagy, Exosomes and HIV-1 Associated Neurological Disorders: New Insights for Diagnosis and Therapeutic Applications
por: Ojha, Chet Raj, et al.
Publicado: (2017)

The Use of Nanotrap Particles Technology in Capturing HIV-1 Virions and Viral Proteins from Infected Cells
por: Jaworski, Elizabeth, et al.
Publicado: (2014)

Assembly of Ebola Virus Matrix Protein VP40 Is Regulated by Latch-Like Properties of N and C Terminal Tails
por: Silva, Leslie P., et al.
Publicado: (2012)

The Human Immunodeficiency Virus 1 ASP RNA promotes viral latency by recruiting the Polycomb Repressor Complex 2 and promoting nucleosome assembly
por: Zapata, Juan C., et al.
Publicado: (2017)

Retroviral infection of human neurospheres and use of stem Cell EVs to repair cellular damage
por: Branscome, Heather, et al.
Publicado: (2022)

Presence of Viral RNA and Proteins in Exosomes from Cellular Clones Resistant to Rift Valley Fever Virus Infection
por: Ahsan, Noor A., et al.
Publicado: (2016)

The sphingosine kinase 1 activator, K6PC-5, attenuates Ebola virus infection
por: Imre, Gergely, et al.
Publicado: (2021)

A Novel Ebola Virus VP40 Matrix Protein-Based Screening for Identification of Novel Candidate Medical Countermeasures
por: Bennett, Ryan P., et al.
Publicado: (2020)

BT-09 Anhidrosis in neurohypophyseal germinoma treated with CBDCA and VP-16
por: Adachi, Koji, et al.
Publicado: (2020)

Effect of Ebola virus proteins GP, NP and VP35 on VP40 VLP morphology
por: Johnson, Reed F, et al.
Publicado: (2006)

Membrane binding and bending in Ebola VP40 assembly and egress
por: Stahelin, Robert V.
Publicado: (2014)

Regulation of Ebola virus VP40 matrix protein by SUMO
por: Baz-Martínez, Maite, et al.
Publicado: (2016)

Identification of Continuous Human B-Cell Epitopes in the VP35, VP40, Nucleoprotein and Glycoprotein of Ebola Virus
por: Becquart, Pierre, et al.
Publicado: (2014)

Integrated Computational Approach for Virtual Hit Identification against Ebola Viral Proteins VP35 and VP40
por: Mirza, Muhammad Usman, et al.
Publicado: (2016)

Chasing Ebola through the Endosomal Labyrinth
por: Aman, M. Javad
Publicado: (2016)

The quest for effective Ebola treatment: Ebola VP35 is an evidence-based target for dsRNA drugs
por: Mitchell, William M, et al.
Publicado: (2014)

Extracellular vesicles from infected cells: potential for direct pathogenesis
por: Schwab, Angela, et al.
Publicado: (2015)

Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate
por: Luke, Thomas, et al.
Publicado: (2018)

Kinetics of Soluble Mediators of the Host Response in Ebola Virus Disease
por: Kerber, Romy, et al.
Publicado: (2018)

Ebola Virus Uses Tunneling Nanotubes as an Alternate Route of Dissemination
por: Djurkovic, Marija A, et al.
Publicado: (2023)

The Ebola Virus VP35 Protein Is a Suppressor of RNA Silencing
por: Haasnoot, Joost, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_11a6bkro5f35tjv3o95vgh83hd